Save time, refresh your knowledge, and on-board your colleagues using the resource pages provided here. Check out our drug discovery resources page for a high-level overview of resources available.
-
- Industry Reviews
Small Molecule Immunomodulators – H1 2021
By Christian Gampe While biologic drugs currently dominate in immunology by sales, small molecule immunomodulators (SMIMs) are making a comeback fueled…13 mins read
-
- Approval Reviews
2020 Small Molecule Drug Approvals
On Jun. 23rd at 11AM PST, Dewakar Sangaraju and Dennis Hu gave a PBSS/CLSA webinar titled “Highlights from 2020’s FDA New Drug Approvals,” organized…5 mins read
-
- Approval Reviews
2020 Large Molecule Drug Approvals
There were 15 novel large molecule drugs approved in 2020, an increase over the 12 large molecule drugs approved in…11 mins read
-
- Reference
Drug Discovery Blogs and Influencers
Reading the thoughts of industry leaders is one of the best ways to grow as a drug discovery professional.…7 mins read
-
- Approval Reviews
- Reference
Approved Covalent Drug Mechanisms
By Dennis Hu It's hard not to think about infectious diseases at the moment, but it's a great time…3 mins read
-
- Industry Reviews
2019 Biotech IPOs – Biologic Drug R&D
Of the 2019 biotech IPOs on the major US exchanges, there were 24 companies focused on developing non-small molecule…2 mins read
-
- Industry Reviews
2019 Biotech IPOs – Small Molecule R&D
Of the 2019 biotech IPOs on the major US exchanges, 25 companies are focused on discovering and developing small…1 min read
-
- Reference
Topliss Tree and Topliss Scheme Posters
This article introduces the Topliss tree and Topliss schemes for analog synthesis, illustrates when they might be useful, and…7 mins read
-
- Reference
Why LogD Matters / ΔLogD Cheat Sheet
This article explains what LogD is, why LogD (or LogP) is important in drug discovery, rookie mistakes in drug…8 mins read
RECENT ARTICLES
- Small Molecule and Biotechnology-Based Therapeutics for Neurology-Focused Companies: 2021’s IPOs Part V
- Agile Drug Hunting
- Lenacapavir Synthesis Highlights
- June 2022 Molecules of the Month Runners-Up
- Molecules of the Month – June 2022
- Beginning with the End in Mind: Five Minutes with a Commercial Leader
DRUG DISCOVERY RESOURCES
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet
- Phase I Drug Metabolism
- Approved Covalent Drug Mechanisms
- Why LogD Matters / LogD Poster
- Types of Kinase Inhibitors
- Unusual Molecular Interactions from the PDB
- Bioactivation of Structural Alerts
- The Square Cube Law
- Don’t Work on Things That Don’t Work
- What is a Biologic Drug Anyway?
- Managing Liver Injury (DILI) Risk
- Where Do Hits Come From?
JOIN SUBSCRIBERS from
- Johnson & Johnson
- Roche
- Pfizer
- Novartis
- Bayer
- Merck
- Sanofi
- GlaxoSmithKline
- AbbVie
- Eli Lilly
- Boehringer Ingelheim
- Amgen
- Bristol-Myers Squibb
- Gilead
- AstraZeneca
- Teva
- Novo Nordisk
- Merck KGaA
- Takeda
- Celgene (BMS)
- Biogen
- Astellas
- Daiichi Sankyo
- Regeneron
- UCB
- Eisai
- Servier
- Kyowa Kirin
- Shionogi
- Vertex
- Lundbeck
- Taisho
- Ono
- Seagen
- Incyte
- LEO Pharma
- Janssen
- Galapagos
- Idorsia
- Astex
- Arvinas
- Kymera
- Relay
- Schrodinger
- Mirati
- Revolution
- Nimbus
- Plexxikon
- Forma
- Arcus
- RA Capital
- ARCH Venture Partners
- MPM Capital
- Orbimed
- The Column Group
- 5AM Ventures
- Versant Ventures
- Deerfield
- Goldman Sachs
- Citi
- Piper Sandler
- Softbank
- …and hundreds of others